Brief Summary
Individual patient expanded access requests may be considered for patients who have no other treatment options
Detailed Description
Expanded access may be available outside of the US in countries prior to approval by the
local regulatory agencies. For full details, please visit the links provided below.
Available
Individual Patients
X-linked Hypophosphatemia
Tumor-Induced Osteomalacia
Biological: Burosumab
Other Name: Array
Eligibility Criteria
Inclusion Criteria:
-
Exclusion Criteria:
-
Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Contacts
Early Access
1-415-483-8800
EarlyAccess@ultragenyx.com
Kyowa Kirin Co., Ltd.
NCT Number
Keywords
Expanded Access
Compassionate Use
XLH
TIO
MeSH Terms
Familial Hypophosphatemic Rickets
Osteomalacia
Hypophosphatemia